EFFECTS OF INTRADERMAL GAMMA-INTERFERON IN CUTANEOUS LEISHMANIASIS
- 1 June 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 333 (8650), 1287-1292
- https://doi.org/10.1016/s0140-6736(89)92686-x
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.The Journal of Experimental Medicine, 1989
- Interferon-Gamma, the Activated Macrophage, and Host Defense Against Microbial ChallengeAnnals of Internal Medicine, 1988
- Liver involvement in human schistosomiasis mansoni. Assessment by immunological and biochemical markersZeitschrift Fur Parasitenkunde-Parasitology Research, 1988
- Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous LeprosyNew England Journal of Medicine, 1986
- American Cutaneous Leishmaniasis: a Comparison of Three Sodium Stibogluconate Treatment Schedules *The American Journal of Tropical Medicine and Hygiene, 1985
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.The Journal of Experimental Medicine, 1983
- Mechanisms of macrophage antimicrobial activityTransactions of the Royal Society of Tropical Medicine and Hygiene, 1983
- Susceptibility of leishmania to oxygen intermediates and killing by normal macrophagesThe Journal of Experimental Medicine, 1981
- Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates.The Journal of Experimental Medicine, 1979